Over 10 years we help companies reach their financial and branding goals. Maxbizz is a values-driven consulting agency dedicated.




411 University St, Seattle


Sona Nanotech Elects New Board Chair and Is Awarded Patent

Sona Nanotech Elects New Board Chair and Is Awarded Patent

Halifax, Nova Scotia — (Newsfile Corp. – May 18, 2023) – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company” or “Sona”), a nanotechnology company developing pre-clinical Targeted Hyperthermia Therapy for colorectal cancer, is pleased to announce the election as chair of the board, Mr. Mark Lievonen, CM, who joined the board of Sona in December 2020.  Mr. Lievonen served as president of Sanofi Pasteur Limited from 1999 to 2016, during which time it became a billion-dollar enterprise in Canada, manufacturing over 50 million doses of vaccines for both domestic and international markets.  A corporate director and principal of JML Advisory Services, Mr. Lievonen also co-chairs Canada’s COVID-19 Vaccine Task Force. 

Mr. Lievonen also serves on a number of public companies and not-for-profit boards, and as an advisor to other businesses and institutions. Mr. Lievonen succeeds Mr. Jim Megann, principal of Numus Financial, who will continue to serve as a director of Sona.   

“I am pleased to take on this role at Sona as the Company moves towards pre-clinical studies for its important Targeted Hyperthermia Therapy, focusing first on colorectal cancer. I’m energized by Sona’s work generating and assembling the pre-clinical study data necessary to secure support from regulators for clinical trials and I look forward to fully contributing towards this goal.” 

Also, as contemplated in the Company’s March 2023 acquisition of Siva Therapeutics, Inc., Leonard Pagliaro, PhD, has been appointed to Sona’s board of directors. Dr. Pagliaro has held senior R&D, business development, and management positions for companies including Eurofins and ThermoFisher Scientific following his academic career at the University of Washington and Carnegie Mellon University, and he holds a PhD in cell biology and biochemistry from Wesleyan University.